SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-034451
Filing Date
2023-02-13
Accepted
2023-02-13 08:30:55
Documents
7
Period of Report
2023-03-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A d426882ddef14a.htm DEF 14A 337574
2 GRAPHIC g426882g0120103503172.jpg GRAPHIC 3630
3 GRAPHIC g426882sp5a.jpg GRAPHIC 9715
4 GRAPHIC g426882sp5b.jpg GRAPHIC 8288
5 GRAPHIC g426882sp5c.jpg GRAPHIC 8143
6 GRAPHIC g426882sp5d.jpg GRAPHIC 8631
7 GRAPHIC g426882sp6.jpg GRAPHIC 8236
  Complete submission text file 0001193125-23-034451.txt   376673
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 SAN DIEGO CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 SAN DIEGO CA 92037 858-369-7800
Metacrine, Inc. (Filer) CIK: 0001634379 (see all company filings)

IRS No.: 472297384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39512 | Film No.: 23614897
SIC: 2834 Pharmaceutical Preparations